Audit of proton pump inhibitor (PPI) prescribing: are NICE guidelines being followed?

被引：9

作者：

Arasaradnam, RP ^{[1
]}

Woodward, T

Parrack, L

Bartlett, L

Bolton, RP

机构：

[1] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England

[2] Doncaster Royal Infirm, Dept Gastroenterol, Doncaster DN2 5LT, England

[3] Doncaster Royal Infirm, Dept Pharm, Doncaster DN2 5LT, England

来源：

CLINICAL MEDICINE | 2003年 / 3卷 / 04期

关键词：

D O I：

10.7861/clinmedicine.3-4-387

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：387 / 388

页数：2

共 5 条

[1] A COMPARISON OF 2 DIFFERENT DOSES OF OMEPRAZOLE VERSUS RANITIDINE IN TREATMENT OF DUODENAL-ULCERS [J].

BARDHAN, KD ;

PORRO, GB ;

BOSE, K ;

DALY, M ;

HINCHLIFFE, RFC ;

JONSSON, E ;

LAZZARONI, M ;

NAESDAL, J ;

RIKNER, L ;

WALAN, A .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 1986, 8 (04) :408-413

[2]

*NAT I CLIN EXC, 2000, GUID US PPI TREATM D

[3]

NEUMANN CS, 1995, ALIMENT PHARM THERAP, V9, P451

[4] COMPARISON BETWEEN RANITIDINE AND OMEPRAZOLE FOR PROTECTION AGAINST GASTRODUODENAL DAMAGE CAUSED BY NAPROXEN [J].

ODDSSON, E ;

GUDJONSSON, H ;

THJODLEIFSSON, B .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (12) :1045-1048

[5] Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus [J].

Wurm, P ;

de Caestecker, J .

EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (07) :1049-1061

← 1 →